Antipsychotic-induced amenorrhea

Journal of Mental Health

Volumn 20, Issue 5, 2011, Pages 484-491

  Seeman, Mary V ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

amenorrhea; antipsychotic; Menstruation; schizophrenia; side effect

Indexed keywords

AMISULPRIDE; ARIPIPRAZOLE; CLOZAPINE; DOPAMINE RECEPTOR STIMULATING AGENT; GONADORELIN; NEUROLEPTIC AGENT; OLANZAPINE; PROLACTIN; QUETIAPINE; RISPERIDONE; ZIPRASIDONE;

AMBIVALENCE; AMENORRHEA; CONTRACEPTION; CULTURAL ANTHROPOLOGY; DELUSION; DENIAL; FEMININITY; FERTILITY; GALACTORRHEA; GENDER IDENTITY; GROUPS BY AGE; GYNECOMASTIA; HIRSUTISM; HUMAN; HYPERPROLACTINEMIA; INFERTILITY; MENOPAUSE; MENSTRUAL IRREGULARITY; MENSTRUATION; OLIGOMENORRHEA; PATIENT MONITORING; PERCEPTION; PSEUDOPREGNANCY; REVIEW; SCHIZOPHRENIA; SEXUAL DYSFUNCTION; SOCIAL SUPPORT;

ADULT; AMENORRHEA; ANTIPSYCHOTIC AGENTS; FEMALE; HUMANS; MIDDLE AGED; SCHIZOPHRENIA; TREATMENT OUTCOME;

EID: 80053286934     PISSN: 09638237     EISSN: 13600567     Source Type: Journal    
DOI: 10.3109/09638237.2011.586741     Document Type: Review

References (63)

1. Abraham, S., Fraser, I., Gebski, V., Knight, C., Llewellyn-Jones, D., Mira, M., et al. (1985). Menstruation, menstrual protection and menstrual cycle problems. The knowledge, attitudes and practices of young Australian women. Medical Journal of Australia, 142, 247-251. (Pubitemid 15066049)
2. Ahuja, N., Moorhead, S., Lloyd, A.J., & Cole, A.J. (2008a). Antipsychotic-induced hyperprolactinemia and delusion of pregnancy. Psychosomatics, 49, 163-167. (Pubitemid 351364991)
3. Ahuja, N., Vasudev, K., & Lloyd, A. (2008b). Hyperprolactinemia and delusion of pregnancy. Psychopathology, 41, 65-68. (Pubitemid 350146916)
4. Andrist, L.C., Hoyt, A., Weinstein, D., & McGibbon, C. (2004). The need to bleed: Women's attitudes and beliefs about menstrual suppression. Journal of the American Academy of Nurse Practitioners, 16, 31-37.
5. Aubeny, A. (2007). Are monthly menstrual periods optional?: A European perspective. Reproductive Health Matters, 15, 183-185.
6. Aydin, Y., Atis, A., Kaleli, S., Uludaǧ, S., & Goker, N. (2010). Cabergoline versus bromocriptine for symptomatic treatment of premenstrual mastalgia: A randomised, open-label study. European Journal of Obstetrics and Gynecology, and Reproductive Biology, 150, 203-206.
7. Baltieri, D.A., & Guerra De Andrade, A. (2009). Schizophrenia modifying the expression of gender identity disorder. Journal of Sexual Medicine, 6, 1185-1188.
8. Beausang, C.C., & Razor, A.G. (2000). Young Western women's experiences of menarche and menstruation. Health Care for Women International, 21, 517-528.
9. Beier, K.M., Wille, R., & Wessel, J. (2006). Denial of pregnancy as a reproductive dysfunction: A proposal for international classification systems. Journal of Psychosomatic Research, 61, 723-730. (Pubitemid 44647256)
10. Bergemann, N., Mundt, C., Parzer, P., Jannakos, I., Nagl, I., Salbach, B., et al. (2005). Plasma concentrations of estradiol in women suffering from schizophrenia treated with conventional versus atypical antipsychotics. Schizophrenia Research, 73, 357-366. (Pubitemid 40093900)
11. Berterö , C. (2003). What do women think about menopause? A qualitative study of women's expectations, apprehensions and knowledge about the climacteric period. International Nursing Review, 50, 109-118. (Pubitemid 37255656)
12. Borras, L., Huguelet, P., & Eytan, A. (2007). Delusional ''pseudotranssexualism'' in schizophrenia. Psychiatry, 70, 175-179.
13. Bostwick, J.R., Guthrie, S.K., & Ellingrod, V.L. (2009). Antipsychotic-induced hyperprolactinemia. Pharmacotherapyz, 29, 64-73.
14. Boughton, M.A. (2002). Premature menopause: Multiple disruptions between the woman's biological body experience and her lived body. Journal of Advanced Nursing, 37, 423-430.
15. Britton, C. (1996). Learning about 'the curse': An anthropological perspective on experiences of menstruation. Women's Studies International Forum, 19, 645-653. (Pubitemid 126401153)
16. Brooke Medicine Eagle. (1991). Buffalo Woman Comes Singing. New York: Ballantine.
17. Davidson, S., Judd, F., Jolley, D., Hocking, B., Thompson, S., & Hyland, B. (2001). Risk factors for HIV/AIDS and hepatitis C among the chronic mentally ill. Australian & New Zealand Journal of Psychiatry, 35, 203-209. (Pubitemid 32377539)
18. Dubravko, H. (2010). Pseudocyesis in peri-and postmenopausal women. Central European Journal of Medicine, 5, 372-374.
19. Edelman, A., Lew, R., Cwiak, C., Nichols, M., & Jensen, J. (2007). Acceptability of contraceptive-induced amenorrhea in a racially diverse group of US women. Contraception, 75, 450-453. (Pubitemid 46764306)
20. Elson, J. (2002). Menarche, menstruation, and gender identity: Retrospective accounts from women who have undergone premenopausal hysterectomy. Sex Roles, 46, 37-48. (Pubitemid 39583127)
21. Estanislau do Amaral, M.C., Hardy, E., Hebling, E.M., & Faundes, A. (2005). Menstruation and amenorrhea: Opinion of Brazilian women. Contraception, 72, 157-161. (Pubitemid 40966988)
22. Ghadirian, A.M., Chouinard, G., & Annable, L. (1982). Sexual dysfunction and plasma prolactin levels in neuroleptic-treated schizophrenic outpatients. Journal of Nervous and Mental Disease, 170, 463-467. (Pubitemid 12051650)
23. Haddad, P.M., & Sharma, S.G. (2007). Adverse effects of atypical antipsychotics: Differential risk and clinical implications. CNS Drugs, 21, 911-936. (Pubitemid 47557106)
24. Haddad, P.M., & Wieck, A. (2004). Antipsychotic-induced hyperprolactinaemia:Mechanisms, clinical features and management. Drugs, 64, 2291-2314. (Pubitemid 39388605)
25. Halbreich, U., & Kahn, L.S. (2003). Hyperprolactinemia and schizophrenia: Mechanisms and clinical aspects. Journal of Psychiatric Practice, 9, 344-353. (Pubitemid 37187616)
26. Hummer, M., & Huber, J. (2004). Hyperprolactinaemia and antipsychotic therapy in schizophrenia. Current Medical Research Opinion, 20, 189-197. (Pubitemid 38197320)
27. Johnston-Robledo, I., Ball, M., Lauta, K., & Zekoll, A. (2003). To bleed or not to bleed: Young women's attitudes toward menstrual suppression. Women Health, 38, 59-75. (Pubitemid 38028720)
28. Kim, J., Kim, S., Kim, S., & Choi, S. (2010). Menstrual irregularities and sex hormones in female patients treated with conventional antipsychotics for more than 5 years. Clinical Psychopharmacology and Neuroscience, 8, 21-25.
29. Kinon, B.J., Gilmore, J.A., Liu, H., & Halbreich, U.M. (2003). Hyperprolactinemia in response to antipsychotic drugs: Characterization across comparative clinical trials. Psychoneuroendocrinology, 28(Suppl 2), 69-82. (Pubitemid 36332230)
30. Kitzinger, C., & Willmott, J. (2002). 'The thief of womanhood': Women's experience of polycystic ovarian syndrome. Social Science & Medicine, 54, 349-361. (Pubitemid 34028117)
31. Knegtering, H., van der Moolen, A.E., Castelein, S., Kluiter, H., & van den Bosch, R.J. (2003). What are the effects of antipsychotics on sexual dysfunctions and endocrine functioning? Psychoneuroendocrinology, 28(Suppl 2), 109-123 (Pubitemid 36335820)
32. Laursen, T.M., & Munk-Olsen T. (2010). Reproductive patterns in psychotic patients. Schizophrenia Research, 121, 234-240.
33. Lee, B.-H., Kim, Y.-K., & Park, S.-H. (2006). Using aripiprazole to resolve antipsychotic-induced symptomatic hyperprolactinemia: A pilot study. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 3, 714-717.
34. Lee, M.S., Song, H.C., An, H., Yang, J., Ko, Y.H., Jung, I.K., et al. (2010). Effect of bromocriptine on antipsychotic drug-induced hyperprolactinemia: Eight-week randomized, single-blind, placebo-controlled, multicenter study. Psychiatry and Clinical Neuroscience, 64, 19-27.
35. Madhusoodanan, S., Parida, S., & Jimenez, C. (2010). Hyperprolactinemia associated with psychotropics -A review. Human Psychopharmacology, 25, 281-297.
36. Marván, M.L., Espinosa-Hernández, G., & Vacio, A. (2002). Premenarcheal Mexican girls' expectations concerning perimenstrual changes and menstrual attitudes. Journal of Psychosomatic Obstetrics and Gynaecology, 23, 89-96.
37. Marván, M.L., & Trujillo, P. (2010). Menstrual socialization, beliefs, and attitudes concerning menstruation in rural and urban Mexican women. Health Care for Women International, 31, 53-67.
38. Miller, K.K. (2004). Management of hyperprolactinemia in patients receiving antipsychotics. CNS Spectrum, 9(Suppl 7), 28-32. (Pubitemid 39180995)
39. Moloney, S. (2010). How menstrual shame affects birth. Women and Birth, 23, 153-159.
40. Montejo, A.L. (2008). Prolactin awareness: An essential consideration for physical health in schizophrenia. European Neuropsychopharmacology, 18(Suppl 2), 108-114.
41. Montgomery, J., Winterbottom, E., Jessani, M., Kohegyi, E., Fulmer, J., Seamonds, B., et al. (2004). Prevalence of hyperprolactinemia in schizophrenia: Association with typical and atypical antipsychotic treatment. Journal of Clinical Psychiatry, 65, 1491-1498.
42. Morrison, L.A., Larkspur, L., Calibuso, M.J., & Brown, S. (2010). Women's attitudes about menstruation and associated health and behavioral characteristics. American Journal of Health Behavior, 34, 90-100.
43. Museum of Menstruation. Retrieved from http://www.mum.org/stopmen.htm.
44. Ostler, T., & Kopels, S. (2010). Schizophrenia and filicide. Current Women's Health Reviews, 6, 58-62.
45. Perkins, D.O. (1999). Adherence to antipsychotic medications. Journal of Clinical Psychiatry, 60, S25-S30.
46. Powell, A.D. (2001). The medication life. Journal of Psychotherapy Practice and Research, 10, 217-222. (Pubitemid 32959172)
47. Roberts, T.A. (2004). Female trouble: The menstrual self-evaluation scale and women's self-objectification. Psychology of Women Quarterly, 28, 22-26.
48. Schooler, D., Ward, L.M., Merriwether, A., & Caruthers, A.S. (2005). Cycles of shame: Menstrual shame, body shame, and sexual decision-making. Journal of Sex Research, 42, 324-334. (Pubitemid 41705650)
49. Shah, A., & Christopherson, R. (2010). Prenatal care for women with schizophrenia. Current Women's Health Reviews, 6, 28-33.
50. Smith, S., Wheeler, M.J., Murray, R., & O'Keane, V. (2002). The effects of antipsychotic-induced hyperprolactinaemia on the hypothalamic- pituitary-gonadal axis. Journal of Clinical Psychopharmacology, 22, 109-114. (Pubitemid 34289384)
51. Solari, H. (2010). Psychotic denial of pregnancy. Current Women's Health Reviews, 6, 22-27.
52. Solari, H., Dickson, K.E., & Miller, L. (2009). Understanding and treating women with schizophrenia during pregnancy and postpartum. Canadian Journal of Clinical Pharmacology, 16, e23-e32.
53. Spielvogel, A.M., & Hohener, H.C. (1995). Denial of pregnancy: A review and case reports. Birth, 22, 220-226.
54. Stubbs, M.L. (2008). Cultural perceptions and practices around menarche and adolescent menstruation in the United States. Annals of the New York Academy of Sciences, 1135, 58-66. (Pubitemid 351862124)
55. Takahashi, H., Higuchi, H., Kamata, M., Naitoh, S., Yoshida, K., Shimizu, T., et al. (2003). Effectiveness of switching to quetiapine for neuroleptic-induced amenorrhea. Journal of Neuropsychiatry and Clinical Neuroscience, 15, 375-377. (Pubitemid 36999384)
56. Torre, D.L., & Falorni, A. (2007). Pharmacological causes of hyperprolactinemia. Therapeutics & Clinical Risk Management, 3, 929-951. (Pubitemid 350162092)
57. Umeora, O.U., & Egwuatu, V.E. (2008). Menstruation in rural Igbo women of south east Nigeria: Attitudes, beliefs and practices. African Journal of Reproductive Health, 12, 109-115.
58. Urban, M. (2009). Transsexualism or delusions of sex change? Avoiding misdiagnosis. Psychiatria Polska, 43, 719-728.
59. Wieck, A., & Haddad, P. (2002). Hyperprolactinaemia caused by antipsychotic drugs. British Medical Journal, 324, 250-252. (Pubitemid 34121831)
60. Wieck, A., & Haddad, P.M. (2003). Antipsychotic-induced hyperprolactinaemia in women: Pathophysiology, severity and consequences. Selective literature review. British Journal of Psychiatry, 182, 199-204. (Pubitemid 36286731)
61. World Health Organization. (1999). How women perceive menstruation and their menstrual pattern. Progress in Reproductive Health Research, 52, 2-3.
62. Yasui-Furukori, N., Saito, M., Nakagami, T., Sugawara, N., Sato, Y., Tsuchimine, S., et al. (2010). Genderspecific prolactin response to antipsychotic treatments with risperidone and olanzapine and its relationship to drug concentrations in patients with acutely exacerbated schizophrenia. Progress in Neuropsychopharmacology and Biological Psychiatry, 34, 537-540.
63. Zhang-Wong, J.H., & Seeman, M.V. (2002). Antipsychotic drugs, menstrual regularity and osteoporosis risk. Archives of Women's Mental Health, 5, 93-98. (Pubitemid 35387786)